149 related articles for article (PubMed ID: 8519655)
1. Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction.
Carr M; May FE; Lennard TW; Westley BR
Br J Cancer; 1995 Dec; 72(6):1427-34. PubMed ID: 8519655
[TBL] [Abstract][Full Text] [Related]
2. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
4. Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.
Knowlden JM; Gee JM; Bryant S; McClelland RA; Manning DL; Mansel R; Ellis IO; Blamey RW; Robertson JF; Nicholson RI
Clin Cancer Res; 1997 Nov; 3(11):2165-72. PubMed ID: 9815611
[TBL] [Abstract][Full Text] [Related]
5. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells.
May FE; Westley BR
J Pathol; 1997 Aug; 182(4):404-13. PubMed ID: 9306961
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence for estrogen and progesterone receptors in human adipose tissue.
Brönnegård M; Ottosson M; Böös J; Marcus C; Björntorp P
J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):275-81. PubMed ID: 7826889
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.
Castles CG; Klotz DM; Fuqua SA; Hill SM
Br J Cancer; 1995 May; 71(5):974-80. PubMed ID: 7734323
[TBL] [Abstract][Full Text] [Related]
8. [Genomic signature in breast cancer: Oncotype DX(®)].
Teig B
Ann Pathol; 2013 Jun; 33(3):225-8. PubMed ID: 23790668
[No Abstract] [Full Text] [Related]
9. Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
McClelland RA; Manning DL; Gee JM; Willsher P; Robertson JF; Ellis IO; Blamey RW; Nicholson RI
Br J Cancer; 1998 May; 77(10):1653-6. PubMed ID: 9635843
[TBL] [Abstract][Full Text] [Related]
10. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pS2 mRNA in breast cancer.
Wysocki SJ; Iacopetta BJ; Ingram DM
Eur J Cancer; 1994; 30A(12):1882-4. PubMed ID: 7880621
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
[TBL] [Abstract][Full Text] [Related]
14. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
15. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.
Rio MC; Chambon P
Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388
[TBL] [Abstract][Full Text] [Related]
16. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
Ruibal A; Arias JI
Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
[No Abstract] [Full Text] [Related]
17. [Estrogen receptor studies in breast cancer based on histological material. Correlation with results from needle biopsy aspirates and pS2 protein determination].
Sauer T; Naess O
Tidsskr Nor Laegeforen; 1995 Sep; 115(23):2881-3. PubMed ID: 7570508
[TBL] [Abstract][Full Text] [Related]
18. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Ree AH; Florenes VA; Berg JP; Maelandsmo GM; Nesland JM; Fodstad O
Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
[TBL] [Abstract][Full Text] [Related]
20. [Specific expression of human pS2 gene in breast cancer].
Rio MC; Bellocq JP; Gairard B; Koehl C; Renaud R; Chambon P
Biochimie; 1988 Jul; 70(7):961-8. PubMed ID: 3145028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
